Compagnie Lombard Odier SCmA’s Takeda Pharmaceutical TAK Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,847	Closed	-$25.4K	–	476
2024 Q3	$26.3K	Hold	1,847	–	–	﹤0.01%	380
2024 Q2	$23.9K	Buy	+1,847	New	+$24.5K	﹤0.01%	376
2021 Q1	–	Sell	-30	Closed	-$1K	–	682
2020 Q4	$1K	Hold	30	–	–	﹤0.01%	559
2020 Q3	$1K	Hold	30	–	–	﹤0.01%	523
2020 Q2	$1K	Hold	30	–	–	﹤0.01%	520
2020 Q1	$0	Hold	30	–	–	﹤0.01%	560
2019 Q4	$1K	Hold	30	–	–	﹤0.01%	514
2019 Q3	$1K	Hold	30	–	–	﹤0.01%	520
2019 Q2	$1K	Hold	30	–	–	﹤0.01%	516
2019 Q1	$1K	Buy	+30	New	+$604	﹤0.01%	566

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Compagnie Lombard Odier SCmA's TAK Position: Q4 2024 in Review

Compagnie Lombard Odier SCmA sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 1,847 shares — an estimated $25.4K sold.

Compagnie Lombard Odier SCmA first reported a position in TAK in Q1 2019 and held it in 10 quarters. The position peaked at $26.3K in Q3 2024. 299 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

Compagnie Lombard Odier SCmA reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 1,847 Takeda Pharmaceutical shares in Q4 2024, an estimated $25.4K.
Compagnie Lombard Odier SCmA first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 10 quarters.
Compagnie Lombard Odier SCmA's Takeda Pharmaceutical position peaked at $26.3K in Q3 2024.
299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2024, filed 30 Jan 2025.